DUBLIN, September 11, 2017 /PRNewswire/ -- The "Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data): Patients Treated" report has been added to Research and Markets' offering.
Globally the Pediatric cancer cases are increasing rapidly at a great pace. Global Pediatric Proton Therapy Market has the potential of more than US$ 700 Million by 2021. United States dominates the proton therapy centers in the world because of its huge investment in the development of therapy centers as well as its elongated history of proton therapy.
Rising incidences of Pediatric cancer has provoked medical organizations towards development and implementation of sophisticated treatment procedures, which is Proton Radiotherapy. The efficiency of proton therapy continues to add trust of Pediatric cancer patients globally. The course of action is known for successfully destructing tumor cells by damaging their DNA during a targeted deposition of high-energy radiation dosage onto the tumor.
Ad Statistics
Times Displayed: 49670
Times Visited: 1409 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
USA has the highest pediatric proton therapy market share but gradually it will lose its market share in future, due to stiff competition from Germany, France, United Kingdom and Japan. This report provides the data on USA Pediatric Proton Therapy Market & Patients numbers, in 36 Cancer Types. Out of these 36 cancer types approximately, 15 percent of market share is taken by Ependymoma cancerous tumor.
The report captures the USA pediatric proton therapy market data on five age groups (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year. In these age groups (1-4) Year has highest market.
Growing number of cancer diagnosed pediatric patients in Europe will enforce the many countries in Europe to expand proton therapy centers because of the demand. Improvement in Technology is playing a very crucial role in driving pediatric proton therapy market in Europe. Germany leads the pediatric proton therapy market in Europe. In 2010, France had the maximum market share of Pediatric Proton Therapy. Other countries studied in the reports are Switzerland, Czech Republic, Sweden, and United Kingdom.
Pediatric Proton therapy technology has immense potential as it is evident from the increasing number of proton therapy centers across Asia. Japan has already established their benchmark for the treatment of pediatric patient with proton therapy. China is more focused toward developing 8 proton therapy centers (Under-construction + Planning Phase) to serve their massive population.
